Net profit of Sun Pharmaceuticals Industries rose 27.98% to Rs 3040.16 crore in the quarter ended September 2024 as against Rs 2375.51 crore during the previous quarter ended September 2023. Sales rose 10.51% to Rs 13264.22 crore in the quarter ended September 2024 as against Rs 12003.11 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 13264.22 | 12003.11 | 11 |
| OPM % | 29.70 | 26.49 | - |
| PBDT | 4223.79 | 3423.70 | 23 |
| PBT | 3597.88 | 2790.88 | 29 |
| NP | 3040.16 | 2375.51 | 28 |